Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia.

Alosaimi FD, Alhabbad A, Abalhassan MF, Fallata EO, Alzain NM, Alassiry MZ, Haddad BA.

Neuropsychiatr Dis Treat. 2016 Apr 19;12:897-907. doi: 10.2147/NDT.S100405. eCollection 2016.

2.

Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor.

Schwartz TL, Siddiqui UA, Stahl SM.

Ther Adv Psychopharmacol. 2011 Jun;1(3):81-7. doi: 10.1177/2045125311409486.

3.

Quality of care for major depression and its determinants: a multilevel analysis.

Duhoux A, Fournier L, Gauvin L, Roberge P.

BMC Psychiatry. 2012 Sep 17;12:142. doi: 10.1186/1471-244X-12-142.

4.

Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use.

Singh M, Schwartz TL.

Neuropsychiatr Dis Treat. 2012;8:123-30. doi: 10.2147/NDT.S20683. Epub 2012 Mar 23.

5.

Clinical and MRI investigation of temporomandibular joint in major depressed patients.

Lopes SL, Costa AL, Cruz AD, Li LM, de Almeida SM.

Dentomaxillofac Radiol. 2012 May;41(4):316-22. doi: 10.1259/dmfr/27328352.

6.

Electroconvulsive therapy for treatment of major depression in a 100-year-old patient with severe aortic stenosis: a 5-year follow-up report.

O'Reardon JP, Cristancho MA, Ryley B, Patel KR, Haber HL.

J ECT. 2011 Sep;27(3):227-30. doi: 10.1097/YCT.0b013e3182293a1c.

7.

Changes in psychotherapy utilization among consumers of services for major depressive disorder in the community mental health system.

Connolly Gibbons MB, Rothbard A, Farris KD, Wiltsey Stirman S, Thompson SM, Scott K, Heintz LE, Gallop R, Crits-Christoph P.

Adm Policy Ment Health. 2011 Nov;38(6):495-503. doi: 10.1007/s10488-011-0336-1.

8.

Health status and lifestyle factors as predictors of depression in middle-aged and elderly Japanese adults: a seven-year follow-up of the Komo-Ise cohort study.

Tanaka H, Sasazawa Y, Suzuki S, Nakazawa M, Koyama H.

BMC Psychiatry. 2011 Feb 7;11:20. doi: 10.1186/1471-244X-11-20.

9.

International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.

Williams LM, Rush AJ, Koslow SH, Wisniewski SR, Cooper NJ, Nemeroff CB, Schatzberg AF, Gordon E.

Trials. 2011 Jan 5;12:4. doi: 10.1186/1745-6215-12-4.

10.
12.

Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy.

Rohde P, Silva SG, Tonev ST, Kennard BD, Vitiello B, Kratochvil CJ, Reinecke MA, Curry JF, Simons AD, March JS.

Arch Gen Psychiatry. 2008 Apr;65(4):447-55. doi: 10.1001/archpsyc.65.4.447.

13.
14.

State of the science on psychosocial interventions for ethnic minorities.

Miranda J, Bernal G, Lau A, Kohn L, Hwang WC, LaFromboise T.

Annu Rev Clin Psychol. 2005;1:113-42. Review. No abstract available.

15.

Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression.

Jordan N, Lee TA, Valenstein M, Weiss KB.

J Gen Intern Med. 2007 Oct;22(10):1447-52. Epub 2007 Aug 9.

16.

Discontinuation of antidepressant medication among Latinos in the USA.

Hodgkin D, Volpe-Vartanian J, Alegría M.

J Behav Health Serv Res. 2007 Jul;34(3):329-42. Epub 2007 Jun 15.

17.

Recognition of depression in older medical inpatients.

Cepoiu M, McCusker J, Cole MG, Sewitch M, Ciampi A.

J Gen Intern Med. 2007 May;22(5):559-64.

18.

Are anxiety and depression addressed in primary care patients with chronic obstructive pulmonary disease? A chart review.

Roundy K, Cully JA, Stanley MA, Veazey C, Souchek J, Wray NP, Kunik ME.

Prim Care Companion J Clin Psychiatry. 2005;7(5):213-8.

19.

Antidepressants and psychotherapy: a clinical research review.

Frank E, Novick D, Kupfer DJ.

Dialogues Clin Neurosci. 2005;7(3):263-72. Review.

20.
Items per page

Supplemental Content

Write to the Help Desk